GE Healthcare of Chalfont St. Giles, U.K., has opened a digital mammography production facility in New York.
The 230,000-sq-ft space is located at the Rensselaer Polytechnic Institute's Technology Park in North Greenbush. It will bring 150 manufacturing jobs to the area; investment in the facility totals more than $165 million, including a capital grant of $10 million from the state of New York, according to GE.
Despite the economic downturn, GE expects the global market for digital mammography technology to grow by 5% over the next few years.
The large scale of the facility matches future demand for digital mammography, according to David Caumartin, general manager of GE's global mammography business.
"In the world, only 25% of women have access to mammography screening," he said. "And even in countries with screening programs, only 25% of women have access to digital. Breast cancer incidence is increasing globally, and there's a need for better digital mammography solutions."
The facility has received the U.S. Green Building Council's LEED Gold certification and is GE's first foray into high-tech medical equipment manufacturing in New York, the company said. The certification process for the plant will take six months, according to Caumartin. GE expects to begin full production of systems in January of next year.
Related Reading
Report: GE hikes price of Tc-99m generators, June 3, 2009
GE partners with LightLab, May 29, 2009
Lantheus completes Definity study enrollment, May 28, 2009
GE wins CZT gamma camera installs, May 28, 2009
Lantheus signs Mo-99 supply deal, May 20, 2009
Copyright © 2009 AuntMinnie.com










![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)






